文献
J-GLOBAL ID:202202265851049661
整理番号:22A0945702
オランダにおけるEGFR変異ステージIV NSCLC患者の特性,生存およびTKI治療の効果を記述する集団ベース研究【JST・京大機械翻訳】
A population-based study describing characteristics, survival and the effect of TKI treatment on patients with EGFR mutated stage IV NSCLC in the Netherlands
著者 (7件):
ten Berge Deirdre M.H.J.
(Dept. of Radiology and Nuclear Medicine, Erasmus MC, Doctor Molewaterplein 40, 3015 GD, Rotterdam, the Netherlands)
,
ten Berge Deirdre M.H.J.
(Dept. of Pulmonary Diseases, Elisabeth-TweeSteden Hospital, Hilvarenbeekseweg 60, 5022GC, Tilburg, the Netherlands)
,
ten Berge Deirdre M.H.J.
(Dept. of Pulmonary Medicine, Erasmus MC Cancer Institute, Doctor Molewaterplein 40, 3015 GD, Rotterdam, the Netherlands)
,
Aarts Mieke J.
(Netherlands Cancer Registry, Netherlands Comprehensive Cancer Organization (IKNL), Godebaldkwartier 419, 3511 DT, Utrecht, the Netherlands)
,
Groen Harry J.M.
(Department of Pulmonary Diseases, University Medical Center Groningen and University of Groningen, Hanzeplein 1, P.o. Box 30001, 9700 RB, Groningen, the Netherlands)
,
Aerts Joachim G.J.V.
(Dept. of Pulmonary Medicine, Erasmus MC Cancer Institute, Doctor Molewaterplein 40, 3015 GD, Rotterdam, the Netherlands)
,
Kloover Jeroen S.
(Dept. of Pulmonary Diseases, Elisabeth-TweeSteden Hospital, Hilvarenbeekseweg 60, 5022GC, Tilburg, the Netherlands)
資料名:
European Journal of Cancer
(European Journal of Cancer)
巻:
165
ページ:
195-204
発行年:
2022年
JST資料番号:
A0802C
ISSN:
0959-8049
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)